- Home
- PROK vs DIBS Comparison
PROK vs DIBS Comparison
Compare PROK & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- DIBS
- Stock Information
- Founded
- PROK 2015
- DIBS 2000
- Country
- PROK United States
- DIBS United States
- Employees
- PROK N/A
- DIBS N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- DIBS Catalog/Specialty Distribution
- Sector
- PROK Health Care
- DIBS Consumer Discretionary
- Exchange
- PROK Nasdaq
- DIBS Nasdaq
- Market Cap
- PROK 85.5M
- DIBS 88.1M
- IPO Year
- PROK N/A
- DIBS 2021
- Fundamental
- Price
- PROK $0.58
- DIBS $2.75
- Analyst Decision
- PROK Hold
- DIBS Hold
- Analyst Count
- PROK 3
- DIBS 1
- Target Price
- PROK $3.50
- DIBS N/A
- AVG Volume (30 Days)
- PROK 1.6M
- DIBS 270.7K
- Earning Date
- PROK 08-08-2025
- DIBS 08-05-2025
- Dividend Yield
- PROK N/A
- DIBS N/A
- EPS Growth
- PROK N/A
- DIBS N/A
- EPS
- PROK N/A
- DIBS N/A
- Revenue
- PROK $306,000.00
- DIBS $88,740,000.00
- Revenue This Year
- PROK $54.34
- DIBS $3.02
- Revenue Next Year
- PROK N/A
- DIBS $6.51
- P/E Ratio
- PROK N/A
- DIBS N/A
- Revenue Growth
- PROK N/A
- DIBS 4.93
- 52 Week Low
- PROK $0.46
- DIBS $2.30
- 52 Week High
- PROK $2.59
- DIBS $5.00
- Technical
- Relative Strength Index (RSI)
- PROK 39.22
- DIBS 51.47
- Support Level
- PROK $0.54
- DIBS $2.67
- Resistance Level
- PROK $0.90
- DIBS $2.95
- Average True Range (ATR)
- PROK 0.13
- DIBS 0.19
- MACD
- PROK -0.03
- DIBS -0.00
- Stochastic Oscillator
- PROK 8.06
- DIBS 30.77
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.